Risk of Stroke and Silent Cerebrovascular Thromboembolism After Cardioversion of Atrial Fibrillation

NCT01924065 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

112

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation
Cardioversion
Cerebrovascular Stroke

Interventions

PROCEDURE: Cardioversion
DRUG: Oral Anticoagulant

Sponsor

Suleyman Demirel University